A recent report by Magic et al. indicated that the introduction of wild-type EFNB2 in breast cancer cells in vitro using stable lentiviral infection was associated with lower cell proliferation, migration and motility compared to controls; in clinical breast cancer specimens, EFNB2 expression was associated with longer patient survival [48]. Here, EFNB2 is linked to breast carcinoma.